How B-cell signaling affects gut microbiota and immune responses
B-cell-intrinsic MHCII Signaling is a Diversifying Force of Selection on IgA Repertoires and the Gut Microbiota
['FUNDING_R01'] · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · NIH-11074543
This study is looking at how certain signals in immune cells called B-cells affect the production of a specific antibody, IgA, and how that might change the types of bacteria living in our gut, which could help us understand more about our immune health and gut balance.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA (nih funded) |
| Locations | 1 site (COLUMBIA, UNITED STATES) |
| Trial ID | NIH-11074543 on ClinicalTrials.gov |
What this research studies
This research investigates the role of B-cell-intrinsic MHCII signaling in regulating immune responses, specifically focusing on immunoglobulin A (IgA) and its influence on gut microbiota composition. By using a specialized mouse model, the study aims to visualize how changes in MHCII affect the diversity of plasma cell populations in the gut. The researchers will analyze genetic variations and their impact on IgA repertoire diversity, which could provide insights into how our immune system interacts with gut bacteria. This work could lead to a better understanding of immune health and gut microbiome dynamics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions affecting gut health or immune responses, particularly those with gastrointestinal disorders.
Not a fit: Patients with no gastrointestinal issues or those not interested in immune system research may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune responses and gut health, potentially leading to improved treatments for gastrointestinal and immune-related conditions.
How similar studies have performed: Previous research has shown promising results in understanding immune system interactions with gut microbiota, suggesting that this approach could yield valuable insights.
Where this research is happening
COLUMBIA, UNITED STATES
- UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA — COLUMBIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KUBINAK, JASON L — UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
- Study coordinator: KUBINAK, JASON L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.